Sobolewski et al36 reported that S100A11/ANXA2 belongs to a tumor oncogene/tumor suppressor gene network, which can be deregulated through steatosis at an early stage, thereby participating in the development of inflammation and HCC. This evidence concerns the gene S100A11 and neoplasm.